AstraZeneca India and Indian Academy of Paediatrics Unite to raise awareness on respiratory syncytial virus in India: Our Bureau, Bengaluru Thursday, November 14, 2024, 16:45 Hrs ...

RSV symptoms include cough, fever, running nose, irritability, reduced activity, and pauses in breathing. Severe cases can ...

help to make World Diabetes Day a global success by providing valuable support for the development of campaign resources and ...

The non-cystic fibrosis bronchiectasis market is driven by rising prevalence linked to respiratory infections, autoimmune diseases, and COPD. Increasing awareness among healthcare providers and ...

Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but ...

High-level results of KOMET, the largest, global randomised double-blind placebo-controlled multicentre Phase III trial in adults with ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday positive data from global KOMET Phase III trial, in which Koselugo ...

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

Bristol-Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Shares were recently up 11% after AbbVie reported ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

AstraZeneca continues to lead development and Amgen continues ... Prevalence of sinonasal outcome test (SNOT-22) symptoms in ...